Patrick Soon-Shiong
CIK 1189020 · See remarks · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
EL SEGUNDO, CA 90245
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | See remarks | 291,526,126 | $7.81 | $2.28B | $0 | 8 | 2026-02-12 |
| Heliogen, Inc. (HLGN.WS) Delisted | 10%+ Owner | 2,345,714 | $0.02 | $43.6K | $5.3K | 1 | 2023-04-17 |
| NantHealth, Inc. (NH) Delisted | Chairman and CEO | 193,286 | $1.35 | $260.9K | $0 | 2 | 2021-09-13 |
| ImmunityBio, Inc. (NK) Delisted | Chairman and CEO | 29,369,076 | — | — | $165.95M | 5 | 2020-06-29 |
| Tribune Publishing Co (TRNC) Delisted | Director | 8,743,619 | — | — | $52.15M | 12 | 2017-03-21 |
| Sorrento Therapeutics, Inc. (SRNE) Delisted | 10%+ Owner | 7,878,098 | $0.00 | $3.9K | -$1.40M | 2 | 2016-07-01 |
| Tribune Publishing Co (TPUB) Delisted | Director | 5,110,057 | — | — | $44.0K | 2 | 2016-06-13 |
| APP Pharmaceuticals, Inc. (ABII) Delisted | Director | 0 | — | — | $0 | 1 | 2008-09-15 |
| APP Pharmaceuticals, Inc. (ABBI) Delisted | Chairman and CEO | 3,286,611 | — | — | $0 | 2 | 2007-10-30 |
Recent Filings · Page 5 of 7
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-25 | ImmunityBio, Inc. (NK) Delisted | Buy (P) | +1,350,000 | $31.05M | EDGAR |
| 2015-08-04 | ImmunityBio, Inc. (NK) Delisted | Grant (A) | +1,800,000 | $0 | EDGAR |
| 2013-04-09 | — | Buy (P) | +1,717,160 | $17.90M | |
| 2010-10-19 | — | Mixed | −33,302,751 | $0 | |
| 2010-03-17 | — | Grant (A) | −125,000 | $0 | |
| 2010-03-03 | — | Tax (F) | −955 | -$31.2K | |
| 2010-02-26 | — | Exer (M) | −165,476 | -$1.31M | |
| 2010-02-11 | — | Other (J) | −8,276 | $0 | |
| 2010-01-26 | — | Tax (F) | −894 | -$36.8K | |
| 2010-01-26 | — | Mixed | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.